Skip to content
EntityQ599160· pop 14· linked from 426 articles

Also known as Optimine®, SCH-10649, 11-(1-Methyl-4-piperidinylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, 6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine, Azatadina, Azatadinum, Azatadin

Azatadine (Optimine) is a first-generation antihistamine and anticholinergic drug that was synthesized in 1963 by Schering-Plough, a former American pharmaceutical company. It is a nitrogen analog of cyproheptadine.

~2 min read

Encyclopedic overview

6 sections
Contents
  • Pharmacology
  • Field of application
  • Mechanism of action
  • Synthesis
  • See also
  • References

Azatadine (Optimine) is a first-generation antihistamine and anticholinergic drug that was synthesized in 1963 by Schering-Plough, a former American pharmaceutical company. It is a nitrogen analog of cyproheptadine.

It was patented in 1967. It has been succeeded by both loratadine and desloratadine. and marketing approvals have been widely withdrawn. == Pharmacology == Azatadine exhibits potent antihistamine, anticholinergic, antiserotonin, and antianaphylactic properties. Its anticholinergic potency is one-third that of atropine and equivalent to that of promethazine and cyproheptadine. Azatadine is among the more potent antianaphylactic agents.

Excerpted from Wikipedia’s “azatadine” article, available under the CC BY-SA 4.0 licence.